Clinical Trials Logo

Filter by:
NCT ID: NCT03043508 Active, not recruiting - Genetic Mutation Clinical Trials

Overall and Disease Specific Survival in Patients With Confirmed MEN1 With or Without PNET (Pancreatic Neuroendocrine Tumors)

Start date: April 10, 2015
Phase:
Study type: Observational

OBJECTIVES: The primary objective of this study is to evaluate the effect of estrogen on the development of the PNET in MEN1 patients. The secondary objective is to evaluate the overall survival and disease specific survival in patients who have confirmed MEN1 with or without PNET and a pancreatic neuroendocrine tumor in relation to their hormone status. The secondary objective is to evaluate clinicopathologic features in relation to hormone status.

NCT ID: NCT02788877 Active, not recruiting - Clinical trials for Macular Edema, Diabetic

Treat-and-extend Regimen of Aflibercept in Diabetic Macular Edema (VIBIM Study)

VIBIM
Start date: April 10, 2016
Phase: Phase 4
Study type: Interventional

Efficacy of Treat-and-extend regimen (TER) using aflibercept in diabetic macular edema (DME) will be evaluated.

NCT ID: NCT02878850 Active, not recruiting - Spinal Cord Injury Clinical Trials

Randomized Trial of Early Hemodynamic Management of Patients Following Acute Spinal Cord Injury

TEMPLE
Start date: April 10, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to learn more about how participants heal from acute spinal cord injury.

NCT ID: NCT03121157 Active, not recruiting - Asthma Clinical Trials

Detroit Young Adult Asthma Project

DYAAP
Start date: April 10, 2017
Phase: N/A
Study type: Interventional

The purpose of the Detroit Young Adult Asthma Project is to test a technology based program to help African American young adults learn to better manage their asthma. Participants will be randomized to a multi-component technology-based intervention (MCTI) targeting asthma medication adherence or to a comparison control condition.

NCT ID: NCT03155061 Active, not recruiting - Clinical trials for Advanced or Metastatic Solid Tumors

Study of ONO-4578 With and Without ONO-4538 in Subjects Advanced or Metastatic Solid Tumors

Start date: April 10, 2017
Phase: Phase 1
Study type: Interventional

The objective of the study is to evaluate the safety, tolerability, pharmacokinetics, efficacy and biomarker of ONO-4578 and combinations of ONO-4578 and ONO-4538 in subjects with advanced or metastatic solid tumors and subjects with unresectable, advanced or recurrent gastric cancer, unresectable, advanced or recurrent colorectal cancer.

NCT ID: NCT03200353 Active, not recruiting - Ulcer Venous Clinical Trials

Evaluation of Sores Treatment by Oxygenotherapy

Start date: April 10, 2017
Phase: N/A
Study type: Interventional

Patient with chronic wounds are selected to receive NATROX system ; it's a continous diffusion of oxygen therapy delivery system. This one is put on the wound during a consultation at the hospital and will be followed in home medical care. Every 2 days a nurse renew the application at home and patient recharge the system with oxygen every day. The complete treatment is prescribe for 4 weeks and at the end patient comes to hospital to have a consultation with the doctor.

NCT ID: NCT03271905 Active, not recruiting - Asthma Clinical Trials

Influence of Mechanical Ventilation Modes on the Efficacy of Nebulized Bronchodilator

Start date: April 10, 2017
Phase: N/A
Study type: Interventional

Aerosol therapy is widely used in intensive care in critically ill patients that use mechanical ventilation (MV). However, there is a lack of standardization about aerosol performance in this group of patients. Thus, this study aims to evaluate the effect of nebulization performed in different ventilatory modes on lung function and regional pulmonary distribution of critical patients with chronic obstructive pulmonary disease. It is a clinical trial, crossover, randomized, controlled and blind. Three interventions with bronchodilators will be performed: in the Pressure Controlled Ventilation mode (PCV) with positive end expiratory pressure (PEEP) = 85% of autoPEEP, in the PCV mode with PEEP = 15 cmH2Oand in the Pressure Support Mode (PSV). Pulmonary function data will be evaluated through Electrical Impedance Tomography to evaluate the efficacy of the bronchodilator in different ventilatory modes.

NCT ID: NCT03330171 Active, not recruiting - Measles Clinical Trials

Safety and Immunogenicity of Measles Vaccine, Varicella Vaccine and Hepatitis-A Vaccine

MV/VV/Hep-AV
Start date: April 10, 2017
Phase: Phase 4
Study type: Interventional

This trial will evaluate the safety and immunogenicity of: i) measles vaccine (CAM-70) after primary dose at 6 months (MV1) and booster vaccination at 12 months (MV2); ii) a single dose of varicella vaccination at 18 months; and iii) a single dose of hepatitis-A vaccination at 18 months in HIV-exposed and HIV-unexposed South African children.

NCT ID: NCT03086993 Active, not recruiting - Clinical trials for Intrahepatic Cholangiocarcinoma

Percutaneous Hepatic Perfusion vs. Cisplatin/Gemcitabine in Patients With Intrahepatic Cholangiocarcinoma

Start date: April 10, 2018
Phase: Phase 2/Phase 3
Study type: Interventional

This study will evaluate two groups of patients who have intrahepatic cholangiocarcinoma. Each group will receive induction treatment with Cisplatin and Gemcitabine per SOC for 4 treatment cycles. Following induction treatment patients will be randomize (1:1), to 2 arms of treatment. One group (50%) will be receive high dose chemotherapy delivered specifically to the liver, while the other group (50%) will continue treatment with Cisplatin and Gemcitabine. Patient in each group will get repeating cycles of treatment until the cancer advances. All patients will be followed until death. This study will compare the overall survival (OS) in patients with intrahepatic cholangiocarcinoma.

NCT ID: NCT03428581 Active, not recruiting - Breast Cancer Clinical Trials

Preventing Lymphedema in Axillary Lymph Node Dissection

Start date: April 10, 2018
Phase: N/A
Study type: Interventional

The researchers are trying to answer if axillary reverse mapping (ARM) with lympho-venous bypass (LVB) in patients undergoing an axillary lymph node dissection reduces the rate and severity of post-operative lymphedema of the arm.